Amsterdam-based Royal Philips and Hologic Inc., based in Marlborough, Mass., have announced a global partnership agreement to offer care professionals integrated solutions comprising diagnostic imaging modalities, advanced informatics, and services for screening, diagnosis, and treatment of women across the world. The collaboration combines Hologic’s innovative mammography technologies and Philips’ portfolio of ultrasound, MRI, CT, and x-ray systems, advanced informatics, and broad range of services, including maintenance, upgrade, training, and operational performance management services. 

“No two women are alike, and we are teaming up with care providers and leading industry partners to support the delivery of a tailored, seamless breast care experience for women,” says Rob Cascella, chief executive of diagnosis and treatment businesses for Royal Philips. “That is why I am very pleased to announce our new partnership with Hologic for mammography. This partnership allows us to offer a complete set of innovative diagnostic imaging systems, software, and services to our customers, including Hologic’s market-leading mammography solutions for breast screening and diagnosis of women in need of care.”

“Hologic believes in enabling doctors with superior technology that improves women’s health through early detection and treatment,” says Pete Valenti, Hologic’s division president of breast and skeletal health solutions. “Our market-leading mammography solutions perfectly complement Philips’ portfolio, making Hologic the right industry partner for this first-of-its-kind collaboration. Now, through the partnership, Hologic can join Philips when engaging with customers on projects that were not previously possible for the two companies alone. It’s a win for everyone involved, including the customers and patients we serve.”

Under the agreement, Philips will be able to offer select products from Hologic’s breast health portfolio as part of multimodality deals for hospitals and health systems, including Hologic’s new 3Dimensions mammography system as well as other technologies for breast screening and interventional radiology.

The multiyear, nonexclusive global partnership agreement allows for customized regional implementation to best meet the individual needs of each customer. The financial details of the agreement were not disclosed.